4.7 Article

Relationship between amyloid and tau levels and its impact on tau spreading

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older Individuals

Laura M. Van der Kall et al.

Summary: The study found that in cognitively normal older individuals, the level of beta-amyloid is related to the risk of progression to mild cognitive impairment or dementia. Higher levels of beta-amyloid were associated with increased risk of developing cognitive decline, indicating a potential biomarker for dementia risk assessment and preclinical AD trial design.

NEUROLOGY (2021)

Article Clinical Neurology

Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease

Sanka Amadoru et al.

ALZHEIMERS RESEARCH & THERAPY (2020)

Article Geriatrics & Gerontology

Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories

Brian J. Lopresti et al.

NEUROBIOLOGY OF AGING (2020)

Article Geriatrics & Gerontology

Impact of APOE-ε4 carriage on the onset and rates of neocortical Aβ-amyloid deposition

Samantha C. Burnham et al.

NEUROBIOLOGY OF AGING (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Clinical impact of [18F]flutemetamol PET among memory clinic patients with an unclear diagnosis

Antoine Leuzy et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)

Article Neurosciences

Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging

Anne Maass et al.

JOURNAL OF NEUROSCIENCE (2018)

Article Clinical Neurology

Longitudinal tau PET in ageing and Alzheimer's disease

Clifford R. Jack et al.

BRAIN (2018)

Article Multidisciplinary Sciences

High performance plasma amyloid-β biomarkers for Alzheimer's disease

Akinori Nakamura et al.

NATURE (2018)

Review Clinical Neurology

Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions

Victor L. Villemagne et al.

NATURE REVIEWS NEUROLOGY (2018)

Article Clinical Neurology

The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET

William E. Klunk et al.

ALZHEIMERS & DEMENTIA (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease

Victor L. Villemagne et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)

Article Medicine, General & Internal

Mild cognitive impairment: a concept in evolution

R. C. Petersen et al.

JOURNAL OF INTERNAL MEDICINE (2014)

Review Neurosciences

ApoE and Aβ in Alzheimer's Disease: Accidental Encounters or Partners?

Takahisa Kanekiyo et al.

NEURON (2014)

Article Clinical Neurology

18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease

Michelle T. Fodero-Tavoletti et al.

BRAIN (2011)

Article Clinical Neurology

A beta Amyloid and Glucose Metabolism in Three Variants of Primary Progressive Aphasia

Gil D. Rabinovici et al.

ANNALS OF NEUROLOGY (2008)

Article Clinical Neurology

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

WE Klunk et al.

ANNALS OF NEUROLOGY (2004)